Target intelligence / Profile preview

Dopamine receptor (D1, D2, D3, D4, D5) (DRD1, DRD2, DRD3, DRD4, DRD5)

Target
DRD1, DRD2, DRD3, DRD4, DRD5
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Dopaminergic signaling refers to the neurotransmission process mediated by dopamine, a key neurotransmitter in the central nervous system. This process involves dopamine binding to its five G protein-coupled receptor subtypes (D1, D2, D3, D4, D5), which are grouped into D1-like and D2-like families. Dopaminergic signaling regulates numerous functions, including movement, motivation, reward, learning, and neuroendocrine activity. Dysregulation of dopaminergic signaling is implicated in various neuropsychiatric and neurodegenerative disorders. Therapeutic targeting involves both stimulation and inhibition of dopamine receptors, depending on disease context.

Other names
Dopaminergic receptorsDA receptorDopamine receptor familyD1-like receptorD2-like receptor
02

Mechanism of action

Agonism at dopamine receptors (stimulate signaling) - Antagonism at dopamine receptors (block signaling) - Modulation of dopamine synthesis, release, or reuptake (e.g., inhibition of dopamine transporter)

03

Biological functions

Signal transductionRegulation of movementReward and reinforcementCognition and memoryNeuroendocrine modulation
04

Disease associations

Neurodegenerative disease (e.g., Parkinson's disease)SchizophreniaDepressionAttention deficit hyperactivity disorder (ADHD)Drug addiction/Substance use disordersOther neuropsychiatric conditions
05

Safety considerations

Movement disorders (e.g., Parkinsonism, tardive dyskinesia)Psychiatric symptoms (e.g., psychosis, agitation, mood changes)Cardiovascular effects (e.g., orthostatic hypotension)Impulse control disorders (with dopamine agonists)
06

Interacting drugs

Levodopa

4 more in the full profile.

07

Biomarkers

Imaging of striatal dopamine transporter binding (e.g., DAT SPECT)CSF dopamine metabolites (e.g., HVA, DOPAC) (indirect)Genetic markers for dopamine receptor polymorphisms (research use)

Beyond the preview

Go deeper on Dopamine receptor (D1, D2, D3, D4, D5) (DRD1, DRD2, DRD3, DRD4, DRD5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine receptor (D1, D2, D3, D4, D5) (DRD1, DRD2, DRD3, DRD4, DRD5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call